BARCLAYS PLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$5,439
+8.2%
342,727
+28.6%
0.00%0.0%
Q2 2023$5,029
+53.9%
266,542
-68.7%
0.00%
+200.0%
Q1 2023$3,267
-15.6%
850,735
+9.0%
0.00%
-50.0%
Q4 2022$3,872
-99.9%
780,649
+27.5%
0.00%
-33.3%
Q3 2022$2,927,000
+3751.3%
612,497
+3482.9%
0.00%
Q2 2022$76,000
-63.6%
17,095
-61.2%
0.00%
Q1 2022$209,000
-97.2%
44,013
-95.6%
0.00%
-100.0%
Q4 2021$7,466,000
+540.3%
1,006,248
+389.2%
0.00%0.0%
Q3 2021$1,166,000
+1.9%
205,696
+18.5%
0.00%0.0%
Q2 2021$1,144,000
-67.1%
173,533
-59.6%
0.00%
-50.0%
Q1 2021$3,481,000
+182.8%
429,654
+125.2%
0.00%
+100.0%
Q4 2020$1,231,000
+65.0%
190,819
-7.9%
0.00%
Q3 2020$746,000
-47.7%
207,213
-33.1%
0.00%
-100.0%
Q2 2020$1,426,000
+207.3%
309,960
+127.5%
0.00%
Q1 2020$464,000
-68.4%
136,255
-52.7%
0.00%
-100.0%
Q4 2019$1,470,000
+140.2%
287,984
+13.9%
0.00%
Q3 2019$612,000
-16.7%
252,846
-25.4%
0.00%
Q2 2019$735,000
+58.1%
338,892
+97.6%
0.00%
Q1 2019$465,000
+33.6%
171,480
+136.5%
0.00%
Q4 2018$348,000
-51.8%
72,520
-4.8%
0.00%
-100.0%
Q3 2018$722,000
-79.2%
76,173
-78.6%
0.00%
-50.0%
Q2 2018$3,464,000
-13.0%
355,933
-5.9%
0.00%
-33.3%
Q1 2018$3,982,000
+775.2%
378,355
+432.8%
0.00%
Q4 2017$455,000
-42.0%
71,006
-30.6%
0.00%
-100.0%
Q3 2017$784,000
+113.0%
102,305
+97.6%
0.00%
Q2 2017$368,000
+68.8%
51,761
-8.2%
0.00%
Q1 2017$218,000
+522.9%
56,377
+220.5%
0.00%
Q4 2016$35,000
+600.0%
17,588
+810.4%
0.00%
Q3 2016$5,000
-99.4%
1,932
-99.3%
0.00%
Q2 2016$881,000
+1857.8%
286,099
+5021.7%
0.00%
Q1 2016$45,000
+164.7%
5,586
+306.3%
0.00%
Q4 2015$17,000
-92.4%
1,375
-94.5%
0.00%
Q3 2015$223,000
+278.0%
24,853
+491.9%
0.00%
Q2 2015$59,000
-97.5%
4,199
-98.6%
0.00%
-100.0%
Q1 2015$2,355,000
+136.2%
294,510
+77.2%
0.00%
+200.0%
Q4 2014$997,000
-31.3%
166,216
+14.5%
0.00%0.0%
Q3 2014$1,451,000
+31.7%
145,149
+44.9%
0.00%0.0%
Q2 2014$1,102,000
-28.4%
100,154
-9.0%
0.00%
-50.0%
Q1 2014$1,540,000
-9.8%
110,037
-9.9%
0.00%0.0%
Q4 2013$1,708,000
-33.9%
122,063
-19.7%
0.00%
-33.3%
Q3 2013$2,584,000
+8.4%
151,992
+5.8%
0.00%0.0%
Q2 2013$2,383,000143,6210.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders